AbbVie reported net earnings of $1.983 billion in the second quarter of 2018 compared with net earnings of $1.915 billion in 2017’s first quarter.
The company posted GAAP net revenues of $8.278 billion in the quarter compared with $6.944 billion a year ago, according to a company press release.
Operating expenses increased from $4.3 million in the second quarter of 2017 to $5.5 billion in the second quarter of 2018.
Global sales of Humira (adalimumab) increased 10% for the quarter to $5.185 billion.
Uncategorized